Zimmer Biomet has begun a deal to acquire OrthoGrid Systems, a privately-held company specializing in artificial intelligence (AI)-driven surgical guidance systems for total hip replacement.
 
This acquisition includes HipAI, OrthoGrid’s AI-powered, fluoroscopy-based surgical assistance platform. ZB will also gain two further U.S. Food and Drug Administration (FDA)-cleared orthopedic applications and more than 40 patents.
 
The HipAI system analyzes images in real-time and has a small OR footprint, according to the company. It also offers automated measurements of leg length and offset, as well as guidance for optimal cup placement. Surgeons can tailor HipAI to match their specific technique and workflow.
 
The transaction is anticipated to close by the end of Q4 2024.
 
“OrthoGrid’s AI systems address the rapidly growing market demand for fluoroscopy-based surgical guidance solutions while strengthening our portfolio of hip offerings that drive intraoperative efficiencies and improve the quality of life for patients,” said Jim Lancaster, president, Recon and global headquarters executive director at Zimmer Biomet.
 
Usually, surgical guidance systems rely on CT-based imaging, which can cause a backlog of CT exams. Fluoroscopy-based guidance uses real-time X-ray imaging to guide procedures and improve surgical accuracy. Fluoroscopy-based systems don’t need pre-op preparation and allow motion imaging to be made at the bedside.
 
OrthoGrid’s AI-enabled surgical guidance technology imports images from C-arm image intensifiers to reveal and correct fluoroscopic distortion.
 
“The agreement with Zimmer Biomet, a global leader in orthopedics, will significantly accelerate our shared goal of addressing challenging orthopedic problems with innovative technology solutions,” said Edouard Saget, co-Founder and co-CEO of OrthoGrid.
 
“While early, the launch of our AI-driven intraoperative surgical guidance platform has received positive feedback from hip surgeons across the U.S. and we are excited to expand our reach through this acquisition,” added Richard Boddington, co-founder and co-CEO of OrthoGrid.
 
In June, Zimmer Biomet began a limited distribution agreement for Think Surgical’s TMINI miniature robotic system for total knee replacement.